Revealing the molecular mechanism of Buzhong Yiqi Decoction for tendon bone healing on the basis of network pharmacology, molecular docking and experimental validation
Shibo Xu,
No information about this author
Yihang Yu,
No information about this author
qizhong xie
No information about this author
et al.
Journal of Ethnopharmacology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 119726 - 119726
Published: April 1, 2025
Language: Английский
SNPs in GPCR Genes and Impaired Osteogenic Potency in Osteoporotic Patient Lines-Based Study
Julia V. Sopova,
No information about this author
Olga Krasnova,
No information about this author
G. I. Vasilieva
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(24), P. 13594 - 13594
Published: Dec. 19, 2024
G-protein-coupled
receptors
(GPCRs)
have
emerged
as
critical
regulators
of
bone
development
and
remodeling.
In
this
study,
we
aimed
to
identify
specific
GPCR
mutations
in
osteoporotic
patients
via
next-generation
sequencing
(NGS).
We
performed
NGS
six
genomic
DNA
samples
taken
from
two
healthy
donors.
Next,
searched
for
single-nucleotide
polymorphisms
(SNPs)
genes
that
are
associated
with
osteoporosis.
For
three
one
donor,
biopsies
were
used
generate
patient-specific
mesenchymal
stem
cell
(MSC)
lines,
their
ability
undergo
osteodifferentiation
was
analyzed.
found
MSCs
derived
a
different
response
osteoinductive
factors
impaired
osteogenic
differentiation
using
qPCR
histochemical
staining
assays.
The
analysis
revealed
combinations
SNPs
these
patients,
where
ADRB2
(rs1042713),
GIPR
(rs1800437),
CNR2
(rs2501431,
rs3003336),
WLS
(rs3762371)
capacity.
By
integrating
data
functional
assessments
linked
formation,
providing
foundation
developing
personalized
therapeutic
strategies.
SNP
is
recognized
proactive
approach
osteoporosis
management,
enabling
earlier
interventions
targeted
preventive
measures
individuals
at
risk.
Furthermore,
contributes
the
robust,
holistic
risk
prediction
models
enhance
accuracy
across
population.
This
integration
genetic
into
public
health
strategies
facilitates
healthcare
initiatives.
could
guide
treatment
decisions
tailored
patient’s
profile
provide
Language: Английский
Insulin for oral bone tissue engineering: a review on innovations in targeted insulin-loaded nanocarrier scaffold
Journal of drug targeting,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 31
Published: Dec. 21, 2024
The
occurrence
of
oral
bone
tissue
degeneration
and
defects
by
osteoporosis,
tooth
extraction,
obesity,
trauma,
periodontitis
are
major
challenges
for
clinicians.
Traditional
regeneration
methods
often
come
with
limitations
such
as
donor
site
morbidity,
limitation
special
shape,
inflammation,
resorption
the
implanted
bone.
treatment
oriented
biomimetic
materials
has
achieved
significant
attention
recently.
In
engineering
arena,
insulin
gained
considerable
among
all
known
biomaterials
osteogenesis
angiogenesis.
It
also
exhibits
osteogenic
angiogenic
properties
interacting
receptors
on
osteoblasts.
Insulin
influences
remodelling
both
directly
indirectly.
acts
through
PI3K/Akt
MAPK
signalling
pathways
indirectly
modulating
RANK/RANKL/OPG
pathway,
which
helps
reduce
resorption.
current
review
reports
role
in
cavity
form
scaffolds
nanomaterials.
Different
delivery
systems,
utilising
nanomaterials
functionalised
polymeric
have
been
explored
regeneration.
put
forward
a
theoretical
basis
future
research
composite
Language: Английский